CORC

在结果中检索

CORC

浏览/检索结果: 共89条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Optimization of the JUNO liquid scintillator composition using a Daya Bay antineutrino detector 期刊论文
NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT, 2021, 卷号: 988, 页码: 10
作者:  Abusleme, A.;  Adam, T.;  Ahmad, S.;  Aiello, S.;  Akram, M.
收藏  |  浏览/下载：42/0  |  提交时间：2021/12/10
Sex differences in the association between socioeconomic status and diabetes prevalence and incidence in China: cross-sectional and prospective studies of 0.5 million adults 期刊论文
2019, 卷号: 62, 期号: 8, 页码: 1420-1429
作者:  Wu, Hongjiang;  Bragg, Fiona;  Yang, Ling;  Du, Huaidong;  Guo, Yu
收藏  |  浏览/下载：7/0  |  提交时间：2020/01/03
Cosmogenic neutron production at daya bay 期刊论文
Physical review d, 2018, 卷号: 97, 期号: 5, 页码: 13
作者:  An, F. P.;  Balantekin, A. B.;  Band, H. R.;  Bishai, M.;  Blyth, S.
收藏  |  浏览/下载：91/0  |  提交时间：2019/04/23
A China-manufactured bevacizumab biosimilar, HLX04, matches bevacizumab sourced from China, USA and the European Union 会议论文
作者:  Ding, Y.;  Yu, T.;  Sun, J.;  Wu, M.;  Chen, Q.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
First china-manufactured proposed rituximab biosimilar met primary efficacy and safety endpoints in CD20-positive diffuse large B-cell lymphoma (generics) 会议论文
作者:  Zhang, H.;  Shi, Y.;  Zhang, Q.;  Han, X.;  Song, Y.
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Zhang, Q.;  Xu, B.;  Zhang, Q.;  Sun, T.;  Li, W.
收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05
Global clinical trials validating bioequivalence with China-manufactured trastuzumab biosimilar, HLX02, and trastuzumab 会议论文
作者:  Xu, B.;  Luk, A.;  Liu, S.;  Jiang, W.;  Liu, E.
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace